Synthesis and Antitumor Activity of 5-Bromo-7-azaindolin-2-one Derivatives Containing a 2,4-Dimethyl-1H-pyrrole-3-carboxamide Moiety

被引：7

作者：

Zhang, Jun ^{[1
,2
,3
]}

Shen, Weiyi ^{[3
]}

Li, Xiaoning ^{[1
,2
]}

Chai, Yun ^{[1
,2
]}

Li, Senjun ^{[3
]}

Lv, Kai ^{[1
,2
]}

Guo, Huiyuan ^{[1
,2
]}

Liu, Mingliang ^{[1
,2
]}

机构：

[1] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China

[2] Peking Union Med Coll, Beijing 100050, Peoples R China

[3] Zhejiang Starry Pharmaceut Co Ltd, Xianju 317300, Peoples R China

来源：

MOLECULES | 2016年 / 21卷 / 12期

关键词：

5-bromo-7-azaindolin-2-ones; synthesis; antitumor activity; KINASE-1; PDK1; INHIBITORS; ANTIBACTERIAL ACTIVITY; GROWTH; DESIGN;

D O I：

10.3390/molecules21121674

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We report herein the design and synthesis of a series of novel 5-bromo-7-azaindolin-2-one derivatives containing a 2,4-dimethyl-1H-pyrrole-3-carboxamide moiety. These newly synthesized derivatives were evaluated for in vitro activity against selected cancer cell lines by MTT assay. Results revealed that some compounds exhibit broad-spectrum antitumor potency, and the most active compound 23p (IC50: 2.357-3.012 mu M) was found more potent than Sunitinib (IC50: 31.594-49.036 mu M) against HepG2, A549 and Skov-3, respectively.

引用

页数：10

共 19 条

[1] RAPID COLORMETRIC ASSAY FOR CELL VIABILITY - APPLICATION TO THE QUANTITATION OF CYTO-TOXIC AND GROWTH INHIBITORY LYMPHOKINES
GREEN, LM
READE, JL
WARE, CF
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 70 (02) : 257 - 268
[2] Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
Houk, Brett E.
Bello, Carlo L.
Poland, Bill
Rosen, Lee S.
Demetri, George D.
Motzer, Robert J.
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (02) : 357 - 371
[3] Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: Design, synthesis and biological activity
Islam, Imadul
Bryant, Judi
Chou, Yuo-Ling
Kochanny, Monica J.
Lee, Wheeseong
Phillips, Gary B.
Yu, Hongyi
Adler, Marc
Whitlow, Marc
Ho, Elena
Lentz, Dao
Polokoff, Mark A.
Subramanyam, Babu
Wu, James M.
Zhu, Daguang
Feldman, Richard I.
Arnaiz, Damian O.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) : 3814 - 3818
[4] Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX-517
Islam, Imadul
Brown, Greg
Bryant, Judi
Hrvatin, Paul
Kochanny, Monica J.
Phillips, Gary B.
Yuan, Shendong
Adler, Marc
Whitlow, Marc
Lentz, Dao
Polokoff, Mark A.
Wu, James
Shen, Jun
Walters, Janette
Ho, Elena
Subramanyam, Babu
Zhu, Daguang
Feldman, Richard I.
Arnaiz, Damian O.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) : 3819 - 3825
[5] Jia X.D., 2016, CHIN CHEM LETT
[6] Kassem MG, 2012, PROF DRUG SUB EXCIP, V37, P363, DOI 10.1016/B978-0-12-397220-0.00009-X
[7] Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors
Kulke, Matthew H.
Bendell, Johanna
Kvols, Larry
Picus, Joel
Pommier, Rodney
Yao, James
[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2011, 4
[8] Angiogenesis inhibitor Z24 induces endothelial cell apoptosis and suppresses tumor growth and metastasis
Lu, HY
Lin, C
Zheng, ZB
Li, S
Guo, SX
Zhang, XY
Fu, M
Liang, X
Wu, M
[J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 (04) : 533 - 540
[9] Synthesis and in vitro antitumor activity of 1-(3-dimethylamino)propyl indolin-2-one derivatives
Lv, Kai
Wang, Li-Li
Zhou, Xin-Bo
Liu, Ming-Liang
Liu, Hong-Ying
Zheng, Zhi-Bing
Li, Song
[J]. MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (04) : 1723 - 1729
[10] Design, Synthesis, and in vitro Antibacterial Activity of Fluoroquinolone Derivatives Containing a Chiral 3-(Alkoxyimino)-2-(aminomethyl)azetidine Moiety
Lv, Kai
Sun, Yexin
Sun, Lanyin
Wei, Zengquan
Guo, Huiyuan
Wu, Jinwei
Liu, Mingliang
[J]. CHEMMEDCHEM, 2012, 7 (07) : 1230 - 1236

← 1 2 →